These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6758923)

  • 1. In vitro antifungal activity of eugenol and vanillin against Candida albicans and Cryptococcus neoformans.
    Boonchird C; Flegel TW
    Can J Microbiol; 1982 Nov; 28(11):1235-41. PubMed ID: 6758923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
    Wei GX; Bobek LA
    J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
    Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
    Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro.
    Qian W; Yang M; Li X; Sun Z; Li Y; Wang X; Wang T
    Colloids Surf B Biointerfaces; 2020 Jul; 191():111003. PubMed ID: 32276211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD; Huston AC
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of phenothiazines against medically important yeasts.
    Eilam Y; Polacheck I; Ben-Gigi G; Chernichovsky D
    Antimicrob Agents Chemother; 1987 May; 31(5):834-6. PubMed ID: 3300543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of antifungal antibiotics on some determinants of virulence in Candida albicans and Cryptococcus neoformans cells.
    Borowski J; Jakoniuk P; Jablońska W; Jakubicz W; Szpak A
    Experientia; 1974 Oct; 30(10):1210-1. PubMed ID: 4611784
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus.
    Faria NC; Kim JH; Gonçalves LA; Martins Mde L; Chan KL; Campbell BC
    Lett Appl Microbiol; 2011 May; 52(5):506-13. PubMed ID: 21332761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal effects of vitamin K3 on Cryptococcus neoformans and Candida albicans.
    Jen TM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Aug; 15(3):250-2. PubMed ID: 6754288
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
    Fromtling RA; Yu HP; Shadomy S
    Mycopathologia; 1984 Apr; 86(1):45-50. PubMed ID: 6330557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
    Gadebusch HH; Pansy F; Klepner C; Schwind R
    J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyoxin D inhibits growth of zoopathogenic fungi.
    Becker JM; Covert NL; Shenbagamurthi P; Steinfeld AS; Naider F
    Antimicrob Agents Chemother; 1983 Jun; 23(6):926-9. PubMed ID: 6351734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of fluconazole, a novel bistriazole antifungal agent].
    Yamaguchi H; Uchida K; Kawasaki K; Matsunaga T
    Jpn J Antibiot; 1989 Jan; 42(1):1-16. PubMed ID: 2540356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising
    Qian W; Li X; Liu Q; Lu J; Wang T; Zhang Q
    Front Cell Infect Microbiol; 2022; 12():884793. PubMed ID: 35669114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal activity of eugenol analogues. Influence of different substituents and studies on mechanism of action.
    Carrasco H; Raimondi M; Svetaz L; Di Liberto M; Rodriguez MV; Espinoza L; Madrid A; Zacchino S
    Molecules; 2012 Jan; 17(1):1002-24. PubMed ID: 22262200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Characterization and Antifungal Evaluation of Novel Thiochromanone Derivatives Containing Indole Skeleton.
    Han XY; Zhong YF; Li SB; Liang GC; Zhou G; Wang XK; Chen BH; Song YL
    Chem Pharm Bull (Tokyo); 2016 Sep; 64(9):1411-6. PubMed ID: 27373770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
    Utz CJ; Shadomy S
    J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans.
    Tsai H; Bobek LA
    Biochim Biophys Acta; 1997 Oct; 1336(3):367-9. PubMed ID: 9367163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.